Publication date: Sep 10, 2026According to a recent report, COVID-19 vaccination among pregnant patients demonstrated a significant impact on healthcare utilization. The study revealed that vaccination led to a 58% ... Read more

Publication date: Sep 10, 2026According to a report analyzing data from 60,980 adults with autoimmune rheumatic conditions, individuals who received booster or updated COVID-19 vaccines demonstrated a significantly reduced risk ... Read more

Publication date: Sep 05, 2026According to this report, researchers developed a “mosaic” nanoparticle vaccine platform that effectively penetrates the viscoelastic mucus barrier of the respiratory system. The vaccine utilizes 5-nanometer ... Read more

Publication date: Aug 28, 2026The purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5 Through 64 Years of ... Read more

Publication date: Aug 25, 2026This Phase 1, multi-center, randomized, double-blind, placebo-controlled, dose-escalation study evaluates the safety, tolerability, and immunogenicity of BMI2012, a self-amplifying RNA vaccine candidate targeting the SARS-CoV-2 Omicron ... Read more

Publication date: Aug 28, 2026According to the report, the FDA approved Comirnaty XFG, a COVID-19 vaccine adapted to target the XFG variant, for individuals aged 5-64 with underlying conditions and ... Read more

Publication date: Aug 25, 2026The purpose of this pragmatic randomized trials is to evaluate the comparative vaccine effectiveness (cVE) of mCombriax(R) (mRNA-1083) versus same day co-administration of the active comparators ... Read more

Publication date: Aug 26, 2026According to a study of nearly 4. 1 million individuals aged 16-25, Pfizer/BioNTech vaccination was associated with a lower risk of myocarditis, pericarditis, and death compared ... Read more